A novel peptide inhibits the influenza virus replication by preventing the viral attachment to the host cells.
Avian influenza viruses (AIV), the causative agent of avian flu or bird flu, cause widespread morbidity and mortality in poultry. The symptoms of the disease range from mild flu like symptoms to death. These viruses possess two important surface glycoproteins, namely hemagglutinin (HA) and neuraminidase (NA) against which neutralizing antibodies are produced. Due to the highly mutative nature of the genes which encode these proteins, the viruses often confer resistance to the current anti-viral drugs making the prevention and treatment of infection challenging. In our laboratory, we have recently identified a novel anti-viral peptide (P1) against the AIV H9N2 from a phage displayed peptide library. This peptide inhibits the replication of the virus in ovo and in vitro by its binding to the HA glycoprotein. In the current study, we demonstrate that the peptide inhibits the virus replication by preventing the attachment to the host cell but it does not have any effect on the viral fusion. The reduction in the viral nucleoprotein (NP) expression inside the host cell has also been observed during the peptide (P1) treatment. This novel peptide may have the potential to be developed as a therapeutic agent for the treatment and control of avian influenza virus H9N2 infections.
Rajik
Mohamed
M
Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, UPM Serdang, Selangor, Malaysia.
Omar
Abdul Rahman
AR
Ideris
Aini
A
Hassan
Sharifah Syed
SS
Yusoff
Khatijah
K
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D002460:Cell Line; D004285:Dogs; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D053127:Influenza A Virus, H9N2 Subtype / Q000187:drug effects* / Q000502:physiology*; D019151:Peptide Library; D010455:Peptides / Q000494:pharmacology*; D016662:Virus Integration / Q000187:drug effects*; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D019151:Peptide Library; D010455:Peptides
Microbes Infect. 2004 Aug;6(10):929-36
15310470
J Virol. 2005 Mar;79(5):2814-22
15709000
Anal Biochem. 1976 May 7;72:248-54
942051
Clin Microbiol Rev. 2006 Jul;19(3):491-511
16847082
N Engl J Med. 2005 Dec 22;353(25):2667-72
16371632
J Virol. 2006 Dec;80(24):11960-7
17005658
Virol J. 2009 Jun 05;6:74
19497129
Int J Med Sci. 2005;2(2):87-90
15968345
J Gen Virol. 1986 Dec;67 ( Pt 12):2813-7
3794667
Curr Opin Infect Dis. 2006 Apr;19(2):169-78
16514342
Infect Immun. 1973 Mar;7(3):341-51
4576677
J Gen Virol. 2005 Feb;86(Pt 2):423-433
15659762
Biochemistry. 1993 Mar 23;32(11):2771-9
8457544
JAMA. 2006 Feb 22;295(8):891-4
16456087
Cell. 1981 Nov;26(3 Pt 1):391-400
7326745
N Engl J Med. 2005 Sep 29;353(13):1363-73
16192481
Antiviral Res. 2007 Mar;73(3):228-31
17112602
Arch Virol. 2002 May;147(5):981-93
12021868
J Virol. 1993 Sep;67(9):5585-94
7688826
Lancet. 2003 Nov 22;362(9397):1733-45
14643124
Nature. 2005 Oct 20;437(7062):1108
16228009